To view the PDF, please see the link below. http://www.rns-pdf.londonstockexchange.com/rns/5860Z_-2016-5-27.pdf SECOND QUARTER 2016 EARNINGS RELEASE ROYAL BANK OF CANADA REPORTS SECOND QUARTER 2016 RESULTS All amounts are in Canadian dollars and are based on financial statements prepared in compliance with International Accounting Standard 34 Interim Financial Reporting, unless otherwise noted. Our Q2 2016 Report to Shareholders and Supplementary Financial Information are available on our website at rbc.com/investorrelations. TORONTO, May 26, 2016-Royal Bank of Canada (RY on TSX and NYSE) today reported net income of $2,573 million for the second quarter ended April 30, 2016, up $71 million or 3% from a year ago. Net income was up $179 million or 7%, excluding a specified item(1) in the prior year as noted below. Results reflect strong earnings in Wealth Management, which benefited from the inclusion of City National Bank (City National), record earnings in Personal & Commercial Banking and higher earnings in Insurance. These factors were partially offset by lower results in Capital Markets and Investor & Treasury Services as compared to strong levels last year. Our results also include favourable foreign exchange translation and continuing benefits from our ongoing focus on efficiency management activities. Our total provision for credit losses (PCL) ratio of 0.36% is comprised of PCL on impaired loans ratio of 0.32% and PCL on loans not yet identified as impaired ratio of 0.04%. PCL on impaired loans ratio increased 7 basis points (bps) from the prior year primarily as a result of the sustained low oil price environment. Compared to last quarter, net income increased $126 million or 5%, mainly reflecting higher earnings in Wealth Management, Insurance, Capital Markets and Personal & Commercial Banking, partially offset by lower earnings in Investor & Treasury Services. This quarter, PCL increased by $50 million ($37 million after -tax) for loans not yet identified as impaired. PCL on impaired loans ratio of 0.32% was relatively flat from last quarter. Our Basel III Common Equity Tier 1 (CET1) ratio strengthened to 10.3%, up 40 bps from the prior quarter. "We delivered a solid quarter, with earnings of over $2.5 billion, reflecting underlying strength across our businesses. I'm very pleased with our performance in the first half of the year with earnings of over $5 billion, particularly in the context of a challenging operating environment," said Dave McKay, RBC President and CEO. "Underpinned by our culture and commitment to putting clients first, RBC continues to be well positioned going forward given the strength of our diversified business model, our prudent risk management and our ability to effectively manage costs." Q2 2016 YTD 2016 compared to YTD 2015 • Net income of $5,020 million (up compared 1% from $4,958 million) • Diluted EPS of $3.25 (down $0.08 from to Q2 $3.33) • ROE of 15.8% (down 350 bps from 19.3%) 2015 • Net income of $2,573 million (up 3% from $2,502 million) • Diluted earnings per share (EPS) of $1.66 (down $0.02 from $1.68) • Return on common equity (ROE)(2) of 16.2% (down 310 bps from 19.3%) • Basel III CET1 ratio of 10.3% (up 30 bps from 10.0%) Excluding Excluding specified item(1) : YTD 2016 compared to YTD 2015 • specified Net income of $5,020 million (up 4% from $4,850 million) • item(1): Diluted EPS of $3.25 (down $0.01 from $3.26) • ROE of 15.8% Q2 2016 (down 310 bps from 18.9%) compared to Q2 2015 • Net income of $2,573 million (up 7% from $2,394 million) • Diluted EPS of $1.66 (up $0.05 from $1.61) • ROE of 16.2% (down 230 bps from 18.5%) The specified item from Q2 2015 is detailed on page 3 and relates to a gain of $108 million (before- and after-tax) from the wind-up of a U.S.-based subsidiary that resulted in the release of foreign currency translation adjustment that was previously booked in other components of equity. Q2 2016 Business Segment Performance Personal & Commercial Banking net income was a record $1,297 million, up $97 million or 8% compared to last year. Canadian Banking net income was $1,241 million, up $50 million or 4% compared to last year, driven by solid volume growth of 6% across most businesses, the positive impact of one additional day in February, and fee-based revenue growth. These factors were partially offset by higher PCL and lower spreads. Caribbean & U.S. Banking net income was $56 million, up $47 million from last year, largely reflecting fee-based revenue growth and lower provisions in the Caribbean portfolio. In addition, the prior year included a loss of $23 million (before- and after-tax) related to sale of RBC Royal Bank (Suriname) N.V. (RBC Suriname). 1 Results and measures excluding the specified item are non-GAAP measures. For further information, including reconciliation, refer to the non -GAAP section on page 3 of this earnings release. 2 This measure does not have a standardized meaning under GAAP. For further information, refer to the Key performance and non-GAAP measures section of our Q2 2016 Report to Shareholders. Compared to last quarter, Personal & Commercial Banking net income was up $7 million or 1%. Canadian Banking net income was up $10 million or 1% compared to last quarter as lower staff costs and higher spreads were partially offset by the negative impact of seasonal factors including fewer days in the current quarter, and higher PCL. Caribbean & U.S. Banking net income was down $3 million. Wealth Management net income of $386 million was up $115 million or 42% from last year, reflecting the inclusion of our acquisition of City National, which contributed $66 million to net income; $108 million(1) excluding amortization of intangibles of $29 million after-tax and $13 million of after-tax integration costs. Results also reflect benefits from our efficiency management activities, lower PCL and lower restructuring costs related to our International Wealth Management business. These factors were partially offset by lower transaction volumes reflecting reduced client activity. Compared to last quarter, net income was up $83 million or 27%, largely reflecting benefits from our efficiency management activities and lower variable compensation driven by lower revenue. Higher earnings in City National driven by loan growth, lower acquisition and integration costs, and higher transaction volumes also contributed to the increase. These factors were partially offset by lower foreign exchange translation. Insurance net income of $177 million was up $54 million or 44% from last year, mainly due to the favourable impact of investment-related gains on our Canadian Life business, and lower net claims costs in both Canadian and International Insurance. Compared to last quarter, net income was up $46 million or 35%, reflecting a tax recovery and lower net claims costs in Canadian Insurance. Investor & Treasury Services net income of $139 million was down $20 million or 13% from last year, mainly driven by continued investment in technology initiatives and lower earnings from foreign exchange market execution reflecting a decrease in client activity. These factors were partially offset by higher earnings on growth in client deposits and the positive impact of foreign exchange translation. Compared to last quarter, net income was down $4 million or 3%, primarily due to lower funding and liquidity results. This factor was partially offset by higher custodial fees and higher earnings on client deposits. Capital Markets net income of $583 million was down $42 million or 7% from last year, primarily due to lower results in Global Markets and Corporate and Investment Banking driven by lower client activity, and higher PCL. These factors were partially offset by lower variable compensation, lower taxes and an increase due to foreign exchange translation. Compared to last quarter, net income was up $13 million or 2%, mainly due to growth in debt and equity origination and higher loan syndication activity. These factors were partially offset by higher litigation and related legal costs, lower foreign exchange translation and lower M&A activity. Corporate Support net loss was $9 million mainly due to the increase of $50 million ($37 million after-tax) in the allowance for credit losses for loans not yet identified as impaired, which was mostly offset by asset/liability management activities. Net income last year of $124 million largely reflected a gain of $108 million (before-and after-tax) from the wind-up of a U.S.-based subsidiary that resulted in the release of a cumulative translation adjustment (CTA) that was previously booked in other components of equity (OCE), as well as asset/liability management activities. In Q2 2015, the gain was identified as a specified item. Capital - As at April 30, 2016, Basel III CET1 ratio was 10.3%, up 40 bps compared to last quarter, largely reflecting strong internal capital generation and lower risk-weighted assets in our market risk portfolios. Credit Quality - Total PCL of $460 million was up $50 million or 12% from last quarter, reflecting an increase in provisions for loans not yet identified as impaired of $50 million ($37 million after-tax). Total PCL ratio was 0.36%, up 5 bps compared to last quarter. PCL on impaired loans of $410 million was flat from last quarter. PCL on impaired loans ratio of 0.32% was relatively flat, up 1 bp, from last quarter. Total gross impaired loans (GIL) of $3,703 million was up $583 million or 19% from last quarter largely due to an increase in impaired oil & gas loans reflecting our bottom-up analysis of the portfolio and considering external factors. The increase in GIL did not warrant a proportionate increase in the allowance given the seniority of our loans and collateral received. Total GIL ratio was 0.71%, up 12 bps compared to last quarter. 1 City National results excluding amortization of intangibles and acquisition and integration costs is a non-GAAP measure that provides readers with a better understanding of management's perspective on our performance. Non-GAAP measures Results and measures excluding • A gain of $108 million (before- and after-tax) in Q2 2015 from the wind-up of a U.S.-based subsidiary that resulted in the release of CTA that was previously booked in OCE; and • $29 million of after-tax amortization of intangibles and $13 million of after-tax integration costs in Q2 2016 related to our acquisition of City National are non-GAAP measures Given the nature and purpose of our management reporting framework, we use and report certain non-GAAP financial measures, which are not defined, do not have a standardized meaning under GAAP, and may not be comparable with similar information disclosed by other financial institutions. We believe that excluding this specified item from our results is more reflective of our ongoing operating results, will provide readers with a better understanding of our performance, and should enhance the comparability of our comparative periods. For further information, refer to the Key Performance and non-GAAP measures section of our Q2 2016 Report to Shareholders.
2nd Quarter Results To view the PDF, please see the link
Top 10 Most Recent News Articles
Stavian Group Eyes AI-Driven Southeast Asia Growth
AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...
Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls
Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...
Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Novo's Semaglutide Shows Promise in MASH Study
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward
A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...
Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings
The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...
Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care
Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...
Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study
Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...
Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue ReadingTop 5 Most Recently Viewed Articles
Brazil Potash Secures $75 Million Equity Line for Growth
Brazil Potash Secures Key Funding for Autazes Project Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE American: GRO), a prominent player in mineral development focused on potash mining, has recently finalized a significant agreement establishing an equity line of credit (ELOC) with Alumni Capital LP. This collaboration signals a crucial step in...
Continue Reading
AGCO Completes Major Strategic Shift Transforming Business Focus
AGCO Completes Divestiture of Grain & Protein Business AGCO Corporation (NYSE: AGCO), a leading firm in agricultural machinery and precision ag technology, has finalized the sale of the majority of its Grain & Protein business to American Industrial Partners (AIP) in an all-cash deal valued at around $700 million. This significant transition emphasizes AGCO's focus on...
Continue Reading
Vincent Bouatou Takes the Helm as CTO at IDEMIA Public Security
Vincent Bouatou Appointed as Chief Technology Officer With a wealth of experience in the technology sector, Vincent Bouatou has been officially announced as the Chief Technology Officer (CTO) of IDEMIA Public Security. His extensive background in driving technological innovations positions him to make significant strides in the biometric technology industry. Driving...
Continue Reading
MedX Holdings, Inc. Reaches New Heights in Q1 Revenue Growth
MedX Holdings, Inc. Reports Extraordinary Q1 Revenue Gains MedX Holdings, Inc. (OTC: MEDH) is delighted to share its impressive financial results for the first quarter of 2025. With record revenue levels and strategic advancements, this milestone reflects the company's commitment to becoming a prominent player in cannabis retail, technology, and franchise development....
Continue Reading
Erste Group Upgrades WW Grainger Stock Amid Positive Outlook
Erste Group upgraded WW Grainger (NYSE: GWW) from Hold to Buy back in mid-2024, showing that the desks had a new favorite. With a return on equity at a whopping 59%, Grainger's performance left many competitors in the dust, making it a must-watch stock for anyone looking to get into industrial supply chains. What's Driving the Upgrade? The reasons behind this rating shift...
Continue Reading